Related Experiment Videos
Primary thyroid lymphoma is a heterogeneous disease.
C Thieblemont1, A Mayer, C Dumontet
1Service d'Hématologie, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite, France. catherine.thieblemont@chu-lyon.fr
The Journal of Clinical Endocrinology and Metabolism
|January 15, 2002
Summary
Thyroid lymphoma (TL) is histologically diverse, with diffuse large B cell lymphoma presenting a poor prognosis and MALT lymphoma associated with Hashimoto
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid lymphoma (TL) is a rare malignancy.
- Understanding its subtypes and clinical behavior is crucial for patient outcomes.
Purpose of the Study:
- To analyze the clinical presentation, subtypes, and prognoses of thyroid lymphoma.
- To differentiate outcomes based on lymphoma subtypes.
Main Methods:
- Retrospective analysis of 26 patients diagnosed with thyroid lymphoma.
- Review of patient demographics, clinical symptoms, medical history, and treatment outcomes.
Main Results:
- Diffuse large B cell lymphoma (50%) had poor prognosis (5-yr survival 44%).
- MALT lymphoma (23%), often linked to Hashimoto thyroiditis, showed excellent prognosis (5-yr survival 100%) with thyroidectomy.
- Histological heterogeneity impacts clinical presentation and prognosis.
Conclusions:
- Thyroid lymphoma exhibits significant histological diversity.
- Clinical presentation and prognosis vary greatly among different TL subtypes.
- MALT lymphoma in Hashimoto thyroiditis patients warrants specific management strategies.